A Multicenter Study Evaluating the Safety and Tolerability of Intravenous rhMBL in Liver Transplant Recipients.

Stopped early · Phase 1

Conditions studied: Liver Transplantation

In brief

This is a multicenter, open-label, randomized, Phase 1B study evaluating liver transplant recipients receiving rhMBL (2 cohorts) or without rhMBL (1 cohort).

Key facts

Study ID

NCT00415311

Run by

Enzon Pharmaceuticals, Inc.

People needed

24

Starts

2006-12-01

Expected to finish

2009-12-01

Last updated by the study team

2011-08-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California San Francisco — San Francisco, California, United States
• Nebraska Medical Center — Omaha, Nebraska, United States
• Mount Sinai School of Medicine — New York, New York, United States
• Vanderbilt University — Nashville, Tennessee, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.